CD163 and neoplasm: Tumor cell-macrophage hybrids express both macrophage (CD14, CD68, CD163, CD204, and CD206) and tumor-specific markers (ALCAM, MLANA, KRT, EpCAM, CXCR4, and CD44) (Clawson et al., 2015).